Adalimumab/etanerceptAlopecia areata: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2013年 / 1477卷 / 1期

关键词：

D O I：

10.1007/s40278-013-6983-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：5 / 5

相关论文

共 50 条

[41] Adalimumab/etanerceptHistoplasmosis: case report
Reactions Weekly, 2015, 1569 (1) : 17 - 17
[42] Adalimumab/etanerceptDermatomyositis: case report
Reactions Weekly, 2013, 1478 (1) : 5 - 5
[43] Adalimumab/etanerceptHepatotoxicity: case report
Reactions Weekly, 2012, 1389 (1) : 7 - 7
[44] Adalimumab/infliximabOsteomyelitis: case report
Reactions Weekly, 2019, 1761 (1) : 19 - 19
[45] Adalimumab/etanerceptTuberculosis: case report
Reactions Weekly, 2020, 1800 (1) : 17 - 17
[46] LeflunomideFirst report of alopecia areata: case report
Reactions Weekly, 2002, 920 (1) : 9 - 9
[47] Adalimumab/etanerceptDementia: case report
Reactions Weekly, 2021, 1852 (1) : 21 - 21
[48] Adalimumab/infliximabKeratopathy: case report
Reactions Weekly, 2014, 1499 (1) : 5 - 5
[49] Adalimumab/etanerceptMenorrhagia: case report
Reactions Weekly, 2023, 1972 (1) : 23 - 23
[50] Adalimumab/infliximabPsoriasis: case report
Reactions Weekly, 2011, 1350 (1) : 8 - 8

← 1 2 3 4 5 →